相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial
Robert S. McKelvie et al.
JOURNAL OF CARDIAC FAILURE (2010)
Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study
Rudolf Berger et al.
EUROPEAN HEART JOURNAL (2009)
Cardiac Resynchronization Therapy Are Modern Myths Preventing Appropriate Use?
John G. F. Cleland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin A Report From CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)
John G. F. Cleland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction
Jasmine Grewal et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Perception of symptoms is out of proportion to cardiac pathology in patients with diastolic heart failure''
L. Ingle et al.
HEART (2008)
Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study
John G. F. Cleland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
How to diagnose diastolic heart failure:: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
Walter J. Paulus et al.
EUROPEAN HEART JOURNAL (2007)
Prognosis in heart failure with a normal ejection fraction
John G. F. Cleland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Use of BNP and CRP as biomarkers in assessing cardiovascular disease: Diagnosis versus risk
Virginia M. Miller et al.
CURRENT VASCULAR PHARMACOLOGY (2007)
Systolic and diastolic heart failure in the community
Francesca Bursi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The perindopril in elderly people with chronic heart failure (PEP-CHF) study
John G. F. Cleland et al.
EUROPEAN HEART JOURNAL (2006)
Outcome of heart failure with preserved ejection fraction in a population-based study
R. Sacha Bhatia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Trends in prevalence and outcome of heart failure with preserved ejection fraction
Theophilus E. Owan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide - Biomarkers for mortality in a large community-based cohort free of heart failure
PM McKie et al.
HYPERTENSION (2006)
The Irbesartan in Heart Failure with Preserved Systolic Function (I-PRESERVE) trial: Rationale and design
P Carson et al.
JOURNAL OF CARDIAC FAILURE (2005)
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
S Yusuf et al.
LANCET (2003)
Burden of systolic and diastolic ventricular dysfunction in the community - Appreciating the scope of the heart failure epidemic
MM Redfield et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function
NP Nikitin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Do patients with suspected heart failure and preserved left ventricular systolic function suffer from diastolic heart failure or from misdiagnosis? A prospective descriptive study
L Caruana et al.
BRITISH MEDICAL JOURNAL (2000)
分享论文
